|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ԭ |
|
���崯 |
| ��������������� | |
|
��־�� |
|
���촺 |
| PubMed | |
|
Article by |
|
Article by |
���崯��ԭ�о���չ
��־��, ���촺
������ҽ��ѧ����ҽԺƤ����, ���� 400038
���崯��һ���Ի������ڲ�����������Ƥ�����γ�ϸ���������Կ���IgG,��������γ�ϸ��������ϸ����𤸽��ɥʧ,���������ɽ�Ϊ��������������Ƥ����,�ٴ�����Ҫ����ΪƤ���Ĥ���ɳ���ˮ�����,����ȷ�еķ��������в����.��Ҫ�������崯��ԭ�Ľṹ���²������Լ�����������е�Ӧ��3������.
[2] Hunt DM, Sahota VK, Taylor K, et al. Clustered cadherin genes:a sequence-ready contig for the desmosomal cadherin locus on human chromosome 18. Genomics, 1999, 62(3):445-455.
[3] Futei Y, Amagai M, Sekiguchi M, et al. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol, 2000, 115(5):829-834.
[4] Wheeler GN, Parker AE, Thomas CL, et al. Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci U S A, 1991, 88(11):4796-4800.
[5] Takeichi M. Cadherins:a molecular family important in selective cellcell adhesion. Annu Rev Biochem, 1990, 59:237-252.
[6] Amagai M, Hashimoto T, Shimizu N, et al. Absorption of pathogenic autoantibodies by the extracellular domain of pomphigus vulgaris antigen(Dsg3)produced by baculovirus. J Clin Invest, 1994, 94(1):59-67.
[7] Amagai M, Karpati S, Prussick R, et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest, 1992, 90(3):919-926.
[8] Zheng J, Kang X, Li W, et al. Molecular cloning and protein expression of ECl-2 and EC3-4 epitopes of pemphigus vulgaris antigen.Chin Med J(Engl), 2000, 113(11):1011-1014.
[9] Sekiguchi M, Futei Y, Fujii Y, et al. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol, 2001, 167(9):5439-5448.
[10] Morioka S, Naito K, Ogawa H. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol,1981,76(5):337-341.
[11] Mahoney MG, Wang ZH, Stanley JR. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol, 1999, 113(1):22-25.
[12] Memar O, Christenserr B, Rajaraman S, et al. Induction of blistercausing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen(desmoglein 3). J Immunol, 1996, 157(7):3171-3177.
[13] Denning MF, Guy SG, Ellerbroek SM, et al. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Exp Cell Res, 1998, 239(1):50-59.
[14] Aoyama Y, Kitajima Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3(Dsg3)from the Triton X-100 soluble pools,leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol,1999, 112(1):67-71.
[15] Koch PJ, Mahoney MG, Ishikawa H, et al. Targeted disruption of the pemphigus vulguris antigen(desmoglein 3)gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol, 1997, 137(5):1091-1102.
[16] Campo-Voegeli A, Muniz F, Mascaro JM, et al. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pomphigus vulgaris. Br J Dermatol, 2002, 147(4):801-805.
[17] Hanakawa Y, Matsuyoshi N, Stanley JR. Expression of desmoglein 1compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.J Invest Dermatol, 2002, 119(1):27-31.
[18] Ishii K, Amagai M, Ohata Y, et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus:antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol, 2000, 42(5 Pt 2):859-861.
[19] Harman KE, Gratian MJ, Shirlaw PJ, et al. The transition of pemphigus vulgaris into pemphigus foliaceus:a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol, 2002, 146(4):684-687.
[20] Cheng SW, Kobayashi M, Kinoshita-Kuroda K, et al. Monitoring disease activity in pomphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol, 2002, 147(2):261-265.
[21] Nishifuji K, Amagai M, Kuwana M, et al. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay:requirement of T cell collaboration for autoantibody production. J Invest Dermatol, 2000, 114(1):88-94.
[22] Proby CM, Ota T, Suzuki H, et al. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris. Br J Dermatol, 2000, 142(2):321-330.